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 What is the central question of this study? 
Premature ventricular activations during clinical electrophysiological testing are 
associated with slowed conduction. It is uncertain whether this change is attributed to 
the prolonged activation latency, or increased impulse propagation time, or both. 
 What is the main finding and its importance? 
Prolonged activation latency at the stimulation site is the critical determinant of 
conduction slowing and associated changes in the ventricular response intervals in 
premature beats initiated during phase 3 repolarization in perfused guinea-pig heart. 
These relations are likely to have an effect on arrhythmia induction and termination, 
independently of the presence of ventricular conduction defects, or the proximity of 
the stimulation site to the re-entrant circuit.  
 
 
 
Abstract 
          During cardiac electrophysiological testing, slowed conduction upon premature 
ventricular activation can limit the delivery of the closely coupled impulses from the 
stimulation site to the region of tachycardia origin. In order to examine the contributing 
factors, in this study, cardiac conduction intervals and refractory periods were determined 
from the left ventricular (LV) and the right ventricular (RV) monophasic action potential 
recordings obtained in perfused guinea-pig hearts. A premature activation induced 
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immediately after the termination of the refractory period was associated with conduction 
slowing.  The latter was primarily accounted for by the markedly increased (+54%) activation 
latency at the LV stimulation site, with only negligible changes (+12%) noted in the LV-to-
RV delay. The prolonged activation latency was acting to limit the shortest interval at which 
two successive action potentials can be induced in LV and RV chamber. The prolongation of 
the activation latency in premature beats was accentuated upon an increase in the stimulating 
current intensity, or during hypokalemia. This change was related to the reduced ratio of 
refractory period to the action potential duration, which allowed extrastimulus capture to 
occur earlier during phase 3 repolarization. Flecainide, Na
+ 
channel blocker, prolonged both 
the activation latency and the LV-to-RV delay, without changing their relative contributions 
into conduction slowing. In summary, these findings suggest that the activation latency is the 
critical determinant of conduction slowing and associated changes in the ventricular response 
intervals upon extrastimulus application during phase 3 of the action potential. 
 
 
Introduction 
          Programmed ventricular stimulation that involves a premature extrastimulus 
application after a train of regular pulses is widely used for testing the inducibility, 
entrainment, and termination of cardiac arrhythmia in patients with a history of recurrent 
ventricular tachycardia or aborted sudden cardiac death (Wellens et al. 1985; Marchlinski et 
al. 1994; Josephson et al. 2014). The efficacy of electrophysiological testing is importantly 
determined by the ability to deliver closely coupled impulses to the region of tachycardia 
origin, which ensures that the premature action potential arrives at the reentrant circuit at a 
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critical time (i.e. during the excitable gap) shortly after previous excitation (Mitchell et al. 
1986; Liem et al. 1988). Importantly, the programmed stimulation protocol is usually applied 
at the ventricular sites remote from the arrhythmic focus. Specifically, the right ventricular 
endocardium is the preferred stimulation site (Wellens et al. 1985; Marchlinski et al. 1994), 
because it is easily accessible via transvenous catheterization, whereas tachycardia in most 
cases originates from the left ventricle (Horowitz et al. 1980; Bogun et al. 2008), because 
myocardial infarction and subsequent arrhythmogenic remodeling more often occur in the left 
ventricular chamber.  
          During electrophysiological testing, a premature activation initiated prior to the full 
repolarization in the previous beat is associated with significant conduction slowing (Ramza 
et al. 1990; Koller et al. 1995a), an effect that limits the shortest interval at which two 
successive electrical responses can be induced at the remote ventricular regions (Mitchell et 
al. 1986; Liem et al. 1988). It is not clear whether conduction slowing upon premature 
activation is primarily attributed to the prolonged stimulus-response latency, or slowed 
impulse propagation from the stimulation site, or both (Liem et al. 1988; Koller et al. 1995b). 
The relative importance of these factors have not been systematically addressed, because 
clinical electrophysiological recordings are usually limited to the right ventricular apex 
(Mitchell et al. 1986; Liem et al. 1988; Koller et al. 1995a), and the impulse propagation time 
at the remote myocardial regions is not assessed. Likewise, measuring the stimulus-response 
latency from the bipolar electrogram recordings in the right ventricle is a challenging task, 
because a large stimulus artifact from the adjacent stimulating electrode is usually 
superimposed on the initial part of the electrogram.  
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          The purpose of the present study was to define the relative contributions of the 
activation latency and the impulse propagation time to the conduction slowing upon 
premature electrical activations induced in perfused guinea-pig hearts. The programmed 
stimulations were applied in the left ventricle, and cardiac conduction intervals were assessed 
by recording the monophasic action potentials at the adjacent (left ventricular) and the remote 
(right ventricular) epicardial sites.  The activation latency and the interventricular conduction 
delay were measured at different coupling stimulation intervals, basic drive cycle lengths, 
stimulating current strengths, and upon interventions known to slow ventricular conduction, 
such as hypokalemia and Na
+
 channel blocker administration.  
Methods 
Ethical approval  
          The present study complies with the European Community Guidelines for the Care and 
Use of Experimental Animals and was approved by the Animal Ethics Screening Committee 
of the Panum Institute (clearance number: 2010/561-1799). Male Dunkin-Hartley guinea-pigs 
(Charles River, Sulzfeld, Germany) weighing 400–500 g were allowed to acclimate to the 
housing conditions, with free access to food and tap water, for at least 7 days prior to entry 
into the study. The experimental procedures used in this study comply with the policies and 
regulations described in the journal guidelines for reporting animal experiments (Grundby, 
2015). 
Isolated, Langendorff-perfused heart preparations 
          The experiments on isolated, perfused hearts were performed as described previously 
(Osadchii et al. 2006; Soltysinska et al. 2011). The guinea-pigs were anesthetized with 
sodium pentobarbital (50 mg/kg i.p.) and anticoagulated with heparin (1000 IU/kg i.p.). The 
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chest was opened, the hearts were immediately excised, mounted on a Langendorff perfusion 
set-up (Hugo Sachs Elektronik-Harvard Apparatus GmbH, March-Hugstetten, Germany) and 
perfused via the aorta at a constant flow (15 ml/min) with carefully filtered, warmed 
physiological saline solution saturated with 95%O2 and 5%CO2. The perfusion solution 
contained (in mM) 118.0 NaCl; 4.7 KCl; 2.5 CaCl2; 25 NaHCO3; 1.2 KH2PO4; 1.2 MgSO4; 
and 10.0 glucose, and had a pH of 7.4. In a subset of experiments with hypokalemic 
perfusions, KCl concentration in the perfusion solution was decreased from 4.7 mM to 2.5 
mM. The aortic perfusion pressure (65-70 mm Hg) was measured with a ISOTEC pressure 
transducer and the coronary flow rate was determined using an ultrasonic flowmeter probe 
(Transonic Systems Inc., USA) placed just above the aortic cannula. The electrical activity of 
the heart preparations was assessed from the volume-conducted ECG as well as monophasic 
action potential recordings. Throughout the experiments, the heart preparations were kept 
immersed in the temperature-controlled, perfusate-filled chamber to minimize thermal loss. 
Aortic pressure, coronary flow rate, ECG and ventricular action potentials were continuously 
monitored using the 16-channel PowerLab system (ADInstruments, Oxford, UK).  
Monophasic action potentials, refractory periods, and electrical stimulations  
          In order to slow the intrinsic beating rate and enable ventricular stimulations at variable 
pacing intervals, both atria were removed and the atrioventricular node was crushed 
mechanically with forceps prior to taking electrophysiological recordings. Epicardial 
monophasic action potentials (MAP) were obtained from the base of the left ventricular (LV) 
and the right ventricular (RV) lateral wall using spring-loaded pressure contact electrodes 
(Hugo Sachs Electronik-Harvard Apparatus GmbH, March-Hugstetten, Germany). The action 
potential duration was measured at 90% repolarization (APD90). For electrical stimulations, 
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the bipolar needle electrodes were placed at LV epicardium close (within 3-4 mm) to the 
adjacent MAP recording electrode. The stimulations were performed with 2 ms rectangular 
pulses generated by a programmable stimulator (Hugo Sachs Electronik-Harvard Apparatus 
GmbH, March-Hugstetten, Germany).  In addition to LV stimulations utilized in the main 
part of the study, in a subset of experiments, the electrical stimulations were applied at RV 
epicardium, close to the RV MAP recording electrode. 
          The programmed stimulation protocol involved an application of the burst of 10 regular 
(S1) pulses followed by a premature extrastimulus (S2) generated at progressively reduced 
coupling intervals (S1–S2).  In successive stimulations, the S1-S2 interval was reduced from 
500 ms to 200 ms in steps of 100 ms, followed by further 5-10 ms decrements until the 
refractoriness was reached. The longest S1-S2 interval that failed to produce ventricular 
capture was normalized by subtracting the activation latency in S1 beat, and taken as the 
effective refractory period (ERP). In parallel, the functional refractory period was determined 
as the shortest ventricular response interval (V1-V2) attained upon progressive reduction of 
the S1-S2 interval (Liem et al. 1988). The V1-V2 interval was measured as the time between 
the action potential upstroke in the last S1 beat in a drive train and the upstroke of the 
following S2-evoked action potential, both in LV and RV MAP-recording sites. 
Ventricular conduction  
          Ventricular conduction intervals were assessed in the last S1 beat in a basic drive train 
and in premature beats upon extrastimulus application, as illustrated in Figure 1. The 
activation latency at the LV stimulation site was measured as the time from the pacing 
stimulus artifact to the fastest upstroke of the following action potential. The LV-to-RV 
conduction delay was determined as the delay between the upstrokes of the LV action 
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potential and the RV action potential. The total conduction time was calculated as a sum of 
the activation latency and the LV-to-RV delay. The minimal ventricular capture interval (e.g. 
the S1-S2 interval applied in the second beat in Fig. 1) is referred to throughout the text as the 
S1-S2 coupling stimulation interval exceeding the ERP by 5 ms.  
Study groups  
          The main data were obtained from three series of experiments in which the electrical 
stimulation protocol was applied at LV epicardium. In the first series (n=9), ventricular 
APD90, refractory periods, and the S2 vs. S1 conduction intervals were measured upon 
variations in parameters of programmed stimulations, namely, the basic drive train cycle 
length (550 ms vs. 300 ms) and the stimulating current intensity (two times vs. five times 
diastolic threshold). The second series (n=11) examined effects produced by hypokalemic 
(2.5 mM KCl) vs. normokalemic perfusion (4.7 mM KCl).  These levels of hypokalemia (2.5 
mM KCl) have been shown to produce significant effects on ventricular repolarization and 
conduction in perfused guinea-pig heart in previous studies (Osadchii et al. 2009; Osadchii, 
2014a). The third series (n=10) assessed electrophysiological changes produced by Na
+
 
channel blocker (flecainide) administration. Ventricular pacing thresholds determined at 
baseline were re-evaluated after hypokalemia or flecainide infusion (both were maintained 
over 30 min), and the pacing output was adjusted as needed. Finally, in the additional set of 
experiments (n=7), ventricular conduction intervals determined in conditions of basal 
normokalemic perfusion during LV stimulations were compared to those obtained with RV 
stimulations. An overview of the experimental series and the used programmed stimulation 
protocols is given in Table 1. 
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Drug adminisrration 
          Flecainide (Sigma-Aldrich, Germany) was infused at a concentration of 1.5 M, which 
is close to the maximum free (i.e. protein-unbound) therapeutic plasma levels (Conard & 
Ober, 1984). For precise dosing, drug infusions were performed at a rate of 0.3 ml/min using 
a calibrated infusion pump, while perfusing the hearts with normokalemic saline solution at a 
constant coronary flow rate (see above). 
Data analysis 
          The data were analysed using Chart 5-Pro for Windows software (ADInstruments).  
Data are expressed as mean + standard deviation of the mean. One-way ANOVA followed by 
the Tukey–Kramer test was used for multiple comparisons, and Student’s paired t-tests were 
used to compare two data sets. P values less than 0.05 were considered to be significant. 
Results 
Ventricular conduction intervals in S2 vs. S1 beats during programmed stimulations  
          Figure 1 shows representative LV and RV monophasic action potential recordings and 
the measurements of ventricular conduction intervals during programmed LV stimulation, 
and Figure 2 shows the summary data that illustrate changes of the activation latency, LV-to-
RV delay, and total conduction time at variable S1-S2 intervals. With a S1-S1 cycle length of 
550 ms, LV and RV APD90 were 163+6 ms and 165+6 ms, respectively. In the last regular 
beat in a basic drive train (indicated as “R” in Fig. 2), the activation latency at the LV 
stimulation site was 12+2 ms, and the LV-RV delay was 16+2 ms, thus yielding the total 
conduction time of 28+2 ms. Upon extrastimulus application, ventricular conduction intervals 
were not changed when premature beats were evoked in late diastole, i.e. at S1-S2 intervals 
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greater than 200 ms (Fig. 2, panels A, B and C). In contrast, extrastimulus application at 
shorter coupling intervals close (within 20 ms) to ERP (indicated as the vertical dashed line) 
was associated with prolongation of the total conduction time, the amount of which was 
progressively increasing upon increasing the S2 prematurity (Fig. 2, panel C). At the shortest 
S1-S2 interval that enabled LV capture (S1-S2 of 172+8 ms), the total conduction time in S2 
beat was increased by 30% compared to its value during S1 pacing. This increase was almost 
entirely accounted for by the markedly prolonged activation latency at the LV stimulation site 
(Fig. 2, panel A), whereas the LV-to-RV delay showed only negligible changes (Fig. 2, panel 
B). Specifically, at the minimal ventricular capture interval, the activation latency was 
increased by 54%, whilst an increment in LV-to-RV delay amounted only 12%, compared to 
the values determined in S1 beat (Fig. 2, panel D).  
          In a subset of experiments, ventricular conduction intervals determined upon LV 
stimulations were compared to those obtained when the stimulation protocol was applied at 
RV epicardium (Fig. 3). At the shortest S1-S2 interval that enabled RV capture (S1-S2 of 
171+6 ms), the % increase in the activation latency in S2 vs. S1 beat (+61%) was much 
greater compared to the increment in RV-to-LV delay (+11%), thus replicating the 
relationships observed with the LV stimulations.  No difference in the activation latency, 
interventricular conduction delay, or total conduction time was observed with RV vs. LV 
stimulations, either in S1- or S2-evoked beats (Fig. 3). 
V1-V2 to S1-S2 relations  
          A prolongation of ventricular conduction upon extrastimulus application can be acting 
to limit the value of the functional response interval in cardiac cells. In Figure 4, these effects 
 
 
 
This article is protected by copyright. All rights reserved. 
 
 
are addressed by plotting the V1-V2 response intervals obtained during programmed LV 
stimulations as a function of the S1-S2 interval. 
          The measurements illustrated in Figure 4A suggest that the V1-V2 interval (i.e., the 
time between the upstrokes of S1- and S2-induced action potentials) at the LV site would be 
equal to the S1-S2 interval if the activation latency is the same in S2 vs. S1 beat (i.e., L1=L2). 
Likewise, the RV response interval is equal to the S1-S2 interval if the LV-to-RV delay is the 
same in S2 vs. S1 beat (i.e., D1=D2). Figure 4B shows that these relations are valid when 
extrastimulus is applied at the long S1-S2 intervals. Indeed, with S1-S2 ranged from 550 ms to 
200 ms, the V1-V2 responses both in LV and RV chamber fall on the identity line, indicating 
that any reduction in S1-S2 interval is followed by a proportional decrease in V1-V2 response 
interval. This is explained by no change in either the activation latency or the LV-to-RV 
delay in S2 vs. S1 beats when extrastimulus is applied in late diastole (Fig. 2, panels A and B). 
Nevertheless, the V1-V2 vs. S1-S2 relations are considerably changed over a range of short 
(less than 200 ms) coupling stimulation intervals (Fig. 4, panel C). In this setting, the V1-V2 
responses deviate from the identity line, with the V1-V2 vs. S1-S2 difference being 
progressively increased upon shortening of the S1-S2 interval. As a result, the minimum V1-V2 
intervals (i.e., the functional refractory periods) attained at the LV and RV MAP recording 
sites during programmed stimulation (LV: 179+8 ms; RV: 181+8 ms) were found to 
significantly exceed the minimum S1-S2 interval that enabled ventricular capture (172+8 ms). 
Importantly, despite the markedly increased V1-V2 vs. S1-S2 difference at the LV site 
(suggesting a prolonged activation latency in S2 vs. S1 beats), the V1-V2 responses in RV 
chamber remained closely aligned to those from LV (Fig. 4, panel C), indicating no 
significant S2 vs. S1  difference in LV-to-RV delay. Thus, it follows that an increase in the 
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activation latency at the stimulation site, rather than in the LV-to-RV delay, is the main factor 
that limits the minimal ventricular response interval in RV chamber during LV stimulations.   
Effects of variations in parameters of programmed stimulation 
S1-S1 cycle length  
         Figure 5 shows effects of varying basic drive train cycle length on the outcomes of 
programmed LV stimulations applied at twice diastolic threshold current intensity. S1-S1 
shortening from 550 ms to 300 ms was associated with proportional reductions in both LV 
APD90 and ERP, translating to no change in ERP-to-APD90 ratio (panels A, D, and G), and 
the repolarization time point for the earliest S2 capture (87% repolarization time with both S1-
S1 cycle lengths). In connection with this, a similar S2 vs. S1 % increase in all conduction 
intervals was determined with both S1-S1 cycle lengths (panels C, F and I). Nevertheless, it is 
noteworthy that independently of the S1-S1 cycle length used, an increase in the total 
conduction time in S2 vs. S1 beats (panel H) was primarily attributable to the prolonged 
activation latency (panel B), with only marginal changes in LV-to-RV delay (panel E). 
S1-S2 stimulating current strength  
         Figure 6 shows effects of varying stimulus intensity on the outcomes of programmed 
LV stimulations applied at S1-S1=550 ms. An increase in the stimulating current strength 
from two to five times diastolic threshold had no effect on LV APD90, but decreased the ERP 
in S1 beat, leading to the reduced ERP-to-APD90 ratio (panels A, D, and G). In S1 beat, the 
activation latency at the LV stimulation site was reduced when using a higher stimulus 
intensity (panel B). The reduced ERP-to-APD90 ratio allowed the S2 capture to occur earlier 
during repolarization phase (77% vs. 87% repolarization time with five times vs. two times 
diastolic threshold, respectively). The increased S2 prematurity contributed to the prolonged 
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activation latency in S2 beats (panel B), resulting in markedly accentuated % increase in the 
activation latency in S2 vs. S1 beats (panel C), when using a higher stimulus intensity.  The S2 
vs. S1 changes in the total conduction time (panels H and I) followed those in the activation 
latency (panels B and C). An increase in the stimulating current strength, however, had no 
effect on the LV-to-RV delay either in S1 or S2 beats (panel E), or its % increment upon 
premature ventricular activation (panel F). 
Effects of hypokalemia 
         Figure 7 illustrates electrophysiological effects produced during hypokalemic as 
compared to normokalemic perfusion. Hypokalemia increased LV APD90, while reducing the 
ERP in S1 beat, thus contributing to the reduced ERP-to-APD90 ratio (panels A, D, and G). 
Consequently, the S2 capture occurred earlier during repolarization phase of a preceding 
action potential (82% vs. 90% repolarization time with hypokalemia vs. baseline, 
respectively). Increased S2 prematurity contributed to the prolonged activation latency in S2 
beats in hypokalemia (panel B), resulting in accentuated % increase in the activation latency 
in S2 vs. S1 beats (panel C). The LV-to-RV delay in hypokalemic hearts was proportionately 
increased in both S1 and S2 beats (panel E), translating to the same S2 vs. S1 % difference, 
when compared to baseline (panel F). Accordingly, the S2 vs. S1 % increase in the total 
conduction time (panel I) in this setting was entirely accounted for by an increment in the 
activation latency in S2 beat (panel C). 
Effects of flecainide  
         Figure 8 illustrates electrophysiological effects produced by flecainide, class Ic Na
+
 
channel blocker. Flecainide prolonged both LV repolarization and refractoriness, with an 
increase in ERP being greater than that in APD90 (panels A and D). As a result, the ERP-to-
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APD90 ratio was increased upon drug administration (panel G), and the S2 capture occurred 
later during final repolarization phase (93% vs. 88% repolarization time with flecainide vs. 
baseline, respectively). The activation latency, the LV-to-RV delay, and the total conduction 
time were proportionately increased in S1 and S2 beats by flecainide (panels B, E, and H), 
translating to the same S2 vs. S1 % differences, when compared to baseline (panels C, F, and 
I). Overall, even though flecainide significantly prolonged all conduction intervals (panels B, 
E, and H), the relative S2 vs. S1 increase in the total conduction time in flecainide-treated 
heart preparations remained to be primarily determined by the prolonged activation latency 
(+46%), with only small changes in LV-to-RV delay (+13%), similar to the S2 vs. S1 relations 
noted at baseline.  
Discussion 
Main findings 
          This study suggests that during programmed stimulations, independently of the S1-S1 
cycle length used, slowed conduction in premature beats initiated shortly after the termination 
of ERP is primarily accounted for by the markedly increased activation latency at the LV 
stimulation site, with only negligible changes occurring in LV-to-RV delay. Increased 
activation latency is acting to limit the minimal ventricular response intervals in LV and RV 
chamber. The prolongation of the activation latency in premature beats is further accentuated 
upon interventions (such as an increase in the stimulating current intensity, or hypokalemia) 
that reduce the ERP-to-APD90 ratio, and hence permit extrastimulus capture earlier during 
phase 3 repolarization. Na
+ 
channel blocker such as flecainide prolongs both the activation 
latency and the LV-to-RV delay in the regular and premature beats, without changing their 
relative contributions into the increment in total conduction time in S2 vs. S1 beats.   
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Changes in the activation latency in S2 vs. S1 beats  
          Extrastimulus applied in late diastole, i.e. when excitability is fully recovered in 
cardiac cells, initiates an action potential with a fast upstroke which rapidly propagates from 
the stimulation site to the adjacent MAP-recording site in LV chamber. This accounts for 
only a brief (about 12 ms) activation latency. In contrast, extrastimulus applied at the shorter 
S1-S2 intervals close to ERP, i.e. prior to the completion of repolarization and full recovery of 
Na
+
 channels from inactivation, typically initiates a slowly rising action potential (Ramza et 
al. 1990), or even a graded response (subthreshold depolarization) which can propagate few 
mm away from the stimulation site and induce a regenerative activation in the distal cells 
with recovered excitability (Hoffman et al. 1957; Gotoh et al. 1997; Karagueuzian & Chen, 
2001). As both slowly rising action potentials and graded responses are associated with 
decreased conduction velocity, the activation latency is markedly prolonged in S2 beats.  
          These changes are amplified upon decreasing the takeoff potential for initiation of the 
premature ventricular responses, consistent with progressively reduced Na
+ 
channel 
availability at incomplete repolarization levels (Weidmann, 1955). Accordingly, the 
prolongation of the activation latency in S2 beats is accentuated upon interventions that 
decrease the ERP-to-APD90 ratio and therefore allow the ventricular capture to occur at the 
earlier repolarization time points; in the present study, this was observed with increasing the 
S1-S2 stimulating current intensity, or upon hypokalemic perfusion. With hypokalemia, the 
contributing mechanism appears to be related to the contrasting changes in APD90 vs. ERP, 
that is, whilst APD90 is prolonged, presumably through inhibition of IKr, the rapid component 
of the delayed rectifier K
+ 
current (Sanguinetti & Jurkiewicz, 1992), the ERP is shortened, 
most likely owing to the hypokalemia effects on the recovery of Na
+
 channels from 
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inactivation in final repolarization phase (Kern et al. 1978; Li et al. 1992). With increased 
stimulating current strength, a reduction in ERP is attributable to the increased amount of 
depolarized myocytes upon extrastimulus application, and therefore improved source-to-sink 
ratio (Kleber & Rudy, 2004), which facilitates initiation of the propagated responses at less 
complete repolarization levels.  
          With flecainide, class Ic Na
+
 channel blocker, changes in the activation latency in 
premature beats are likely to be determined by an interplay of several factors. Whilst 
flecainide can moderately prolong APD90 owing to its inhibitory effect on IKr (Wang et al. 
1996; Melgari et al. 2015), it produces more prominent ERP lengthening in connection with 
its INa blocking effects, which is leading to the increased ERP-to-APD90 ratio. The latter 
postpones the initiation of the earliest S2 response towards a later repolarization time point, 
an effect that can be expected to prevent a prolongation of the activation latency in S2 vs. S1 
beats, assuming a greater Na
+
 channel availability at more negative membrane potentials 
(Weidmann, 1955). This voltage-dependent change, nevertheless, is balanced by the drug-
induced INa block, which is leading to the reduced number of Na
+
 channels recovered from 
inactivation at a given level of the membrane potential throughout the repolarization phase 
(Glaaser & Clancy, 2006). As a result, flecainide effects during programmed stimulations 
appear to be mostly related to the increase in S1-S2 interval at which the activation latency 
starts to be prolonged upon S2 applications with increasing proximity to a preceding action 
potential, whereas the magnitude of the S2 vs. S1 increment in the activation latency is not 
significantly changed (Fig. 8, panel C).     
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Changes in the LV-to-RV delay in S2 vs. S1 beats  
          The velocity of the action potential upstroke (Vmax) is thought to be the primary 
determinant of the conduction time in premature ventricular beats (Weidmann, 1955; Ramza 
et al. 1990). When a premature activation is initiated in incompletely repolarized cells prior 
to the full recovery of Na
+
 channels, the Vmax is reduced and the conduction is slowed. The 
present study, nevertheless, suggests that these changes are minimized in the setting of the 
prolonged activation latency. An increase in the activation latency ensures that cellular 
repolarization can proceed for 18-20 ms after the extrastimulus application, until it is 
interrupted by a premature action potential (Fig. 1 and Fig. 2, panel A). As the moment for 
initiation of the premature activation is postponed towards a later repolarization time point 
whereby more Na
+ 
channels have recovered from inactivation, the expected Vmax reduction in 
S2 beat is minimized, which translates to only marginal (+12%, Fig. 2, panel D) increase in 
the LV-to-RV delay, compared to its value in the regular beat.  
          Ventricular conduction is known to be slowed upon drug-induced Na
+
 channel 
blockade, as well as in the setting of hypokalemia that is acting by increasing the ventricular 
excitation threshold secondary to hyperpolarization of the cardiac myocyte sarcolemma, an 
effect attributable to the suppression of IK1, the inward rectifier K
+ 
current (Weiss et al. 
2017). In this study, even though hypokalemia and flecainide were found to significantly 
increase the LV-to-RV delay in both S1 and S2 beats (panel E in Figs. 7 and 8), the % 
increment in the LV-to-RV delay in S2 vs. S1 beats remained the same (panel F in Figs. 7 and 
8). The latter can be partly explained by a prolongation of the activation latency in S2 beats in 
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both settings (panel B in Figs. 7 and 8), with a subsequent effect on timing of the premature 
activation in the late repolarization phase.  
          Overall, the aforementioned changes imply that an increase in the activation latency 
upon premature ventricular activation may represent an intrinsic regulation that prevents a 
significant slowing of the conduction velocity with which the initiated depolarization wave 
spreads away from the stimulation site. 
Clinical implications 
          The conventional clinical electrophysiological techniques do not allow to discriminate 
whether conduction slowing upon premature activation is attributed to the prolonged 
activation latency, or slowed impulse propagation away from the stimulation site, or both. 
The endocardial electrogram recordings performed during electrophysiological testing are 
invariably limited to the RV chamber (Wellens et al. 1985; Mitchell et al. 1986; Liem et al. 
1988; Koller et al. 1995a), and hence do not permit the evaluation of the interventricular 
conduction delay. The monophasic action potential recordings in cardiac patients are 
technically complicated and therefore not used in the daily clinical work. With other 
techniques, for example, the pace mapping which is designed to locate the arrhythmia source 
by pacing at multiple endocardial sites, ventricular conduction time is assessed by measuring 
the interval between the pacing stimulus artifact and the onset of the QRS complex on the 
surface ECG (Brunckhorst et al. 2003). Although this can provide a crude measure of slow 
conduction, the contributing physiological factors remain uncertain. In this regard, the present 
study suggests that a significant part of the large-scale conduction delay measured during 
clinical testing may be related to the increased activation latency at the stimulation site, rather 
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than conduction slowing away from it, at least during premature activations initiated during 
phase 3 repolarization.    
          Another practical aspect of this study is related to the impact of the activation latency 
on the ventricular response interval. It is generally assumed that ERP reduction is invariably 
leading to the reduced minimal interval for successive ventricular activations, which results 
in the faster excitation rate during induced tachyarrhythmia, and renders it less responsive to 
antiarrhythmic drugs (Opthof et al. 1991; Wu et al. 2002; Chen et al. 2003). However, with 
interventions that prolong the activation latency in S2 beats (e.g. hypokalemia, or increased 
stimulating current intensity), the ERP reduction would likely to be associated with no 
change in the minimal ventricular response interval (i.e., the functional refractory period), 
thus eliminating the possibility for accelerated excitation frequency. These relationships, 
therefore, challenge the value of assessments aimed at predicting the activation frequency 
during tachyarrhythmia based on measuring the ERP alone. 
Impact of hypokalemia and flecainide 
          Importantly, cardiac electrophysiological changes produced by hypokalemia or 
flecainide are likely to be of clinical relevance. Indeed, hypokalemia represents the most 
common electrolyte disorder seen in cardiac patients, which typically develops as a side 
effect of diuretic therapy, or may be caused by neurohormonal derangements in heart failure 
(Weiss et al. 2017).  Hypokalemia occurs in about 16% of patients admitted to the hospital 
(Jensen et al. 2015), and it plays an important role in cardiac arrhythmogenesis by facilitating 
the arrhythmic triggers, such as the early and delayed afterdepolarizations, and by causing 
conduction slowing and repolarization derangements, which precipitate re-entry (Weiss et al. 
2017). With flecainide, an increase in the risk of arrhythmic death has been found in patients 
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with healed myocardial infarction enrolled in the CAST trial (CAST Investigators, 1989). 
The flecainide-induced arrhythmia is thought to be attributed to the multiple mechanisms, 
including non-uniform conduction slowing in myocardial regions bordering the post-
infarction scar (Ranger & Nattel, 1995), and amplified spatial repolarization gradients 
(Osadchii, 2014b). Flecainide, nevertheless, remains one of the first line treatments used for 
the rhythm control in atrial fibrillation in patients with structurally normal hearts (Apostolakis 
et al. 2013). This agent is also considered as a promising treatment option in patients with 
catecholaminergic polymorphic ventricular tachycardia (Salvage et al. 2018). Overall, these 
clinical findings, in connections with the results of the present study, strongly suggest that 
both hypokalemia and flecainide treatment should be considered among those factors which 
can influence the outcomes of ventricular conduction assessments and associated 
arrhythmogenicity during programmed stimulations in cardiac patients. 
Activation latency in the premature beats: the contributing mechanisms  
          The activation latency measured at the LV stimulation site has a complex mechanism, 
and includes both the time needed to initiate the action potential, and the time taken for the 
action potential to propagate from the stimulating electrodes to the adjacent MAP-recording 
electrodes. Importantly, the S2 application is known to produce a greater conduction slowing 
close to the pacing site than in distant myocardial regions (Koller et al.1995a, 1995b; 
Karagueuzian & Chen, 2001), an effect that can be partly attributed to the impaired source-
sink relationships (Kleber & Rudy, 2004). With point stimulation, the amount of depolarized 
cells (i.e., the source) is small, and the initiated depolarization wavefront is very convex, 
which contributes to the dissipation of the excitatory current over a large downstream 
myocardial area (i.e., the sink). The resulting source-sink mismatch then may account for the 
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low conduction velocity with which the impulse spreads away from the pacing site. Upon 
subsequent ventricular activation, the area of depolarized cells is progressively increased, and 
the wavefront curvature is reduced, thus improving the source-sink ratio, and reducing the 
degree of conduction slowing at the distant sites. With these considerations, it can be 
assumed that upon S2 application in late diastole, a significant part of the activation latency is 
attributed to the local conduction slowing in the immediate vicinity of the stimulating 
electrode, rather than to the time needed to initiate a premature action potential. These 
relations, nevertheless, can be significantly changed upon S2 application during phase 3 
repolarization (i.e., in close proximity to ERP) in the preceding S1 beat (Fig. 1). In the setting 
of the reduced Na
+
 channel availability in incompletely repolarized cardiac cells (Weidmann, 
1955), the S2 application evokes a depolarizing graded response that slowly attains the 
threshold voltage for generating action potential upstroke (Hoffman et al. 1957; Gotoh et al. 
1997; Karagueuzian & Chen, 2001). Consequently, the initiation of the propagating action 
potential is significantly delayed. Therefore, when S2 is applied shortly after the termination 
of ERP, the prolonged time for initiation of the premature action potential is likely to be an 
independent factor that contributes to the activation latency at the stimulation site.  
Limitations 
          In this study, action potential recordings were performed at only two sites in the LV 
and RV epicardium, thus providing no information on the pathway of electrical activation 
during programmed stimulation, and precluding the assessments of the conduction velocity. 
Spatiotemporal mapping studies that involve optical action potential recordings at multiple 
ventricular sites are warranted in order to assess more precisely the relative contribution of 
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the activation latency at the stimulation site and the LV-to-RV delay into the mechanism of 
conduction slowing in premature beats. 
Conclusions 
          During cardiac electrophysiological testing, prolonged activation latency at the 
stimulation site should be considered as the critical determinant of conduction slowing and 
associated changes in the ventricular response intervals in premature beats initiated shortly 
after the termination of effective refractory period. 
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Figure 1. Assessments of the activation latency, LV-to-RV conduction delay, and total 
conduction time from monophasic action potential recordings obtained during programmed 
stimulations. 
Representative monophasic action potentials from the left ventricular (LV, upper trace) and 
the right ventricular (RV, lower trace) epicardium were recorded during S1-S2 stimulations 
applied in LV chamber. Conduction intervals were assessed in the last regular (S1) beat in a 
drive train, and in a premature beat upon an application of extrastimulus (S2). The activation 
latencies in the regular beat (L1) and in the premature beat (L2) were measured from the 
moment of S1 and S2 application, respectively, to the fastest upstroke of the following action 
potential (vertical dotted line). The LV-to-RV conduction delays in the regular beat (D1) and 
in the premature beat (D2) correspond to the delays between the upstrokes of the LV action 
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potential and the RV action potential upon S1 and S2 application, respectively. The total 
conduction time in the regular beat (CT1) is a sum of L1 and D1, and the total conduction time 
in the premature beat (CT2) is a sum of L2 and D2. Note that S2 application at the shortest 
coupling interval that allows ventricular capture is associated with markedly increased 
activation latency (L2 is greater than L1), but no significant change in the LV-to-RV delay (D2 
is similar to D1), compared to the values determined in S1 beat. 
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Figure 2. Dynamics of the activation latency, LV-to-RV delay, and total conduction time at 
variable S1-S2 coupling stimulation intervals. 
During programmed stimulations, the LV activation latency (panel A), LV-to-RV delay 
(panel B), and total conduction time (panel C) were measured upon progressive shortening of 
the S1-S2 interval towards the minimal values slightly exceeding the effective refractory 
period (ERP, the vertical dashed line). “R” denotes to the values of conduction intervals 
measured in the last regular beat in a drive train prior to extrastimulus application. Panel D 
shows % increase in LV activation latency and LV-to-RV delay in S2 beats evoked at the 
shortest ventricular capture interval, compared to the values determined in S1 beats. *P<0.05. 
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Figure 3. Ventricular conduction intervals determined during programmed stimulations 
applied at LV vs. RV epicardium. 
Programmed stimulations (stim) were applied with S1-S1 cycle length of 550 ms at twice 
diastolic threshold current intensity, either in LV (open bars) or RV chamber (hatched bars).  
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Figure 4. Relations between ventricular V1-V2 response intervals and S1-S2 coupling 
stimulation intervals. 
V1-V2 intervals were determined in LV and RV MAP-recording sites (panel A), and then 
plotted vs. S1-S2 intervals (panels B and C). L1 and L2 are the activation latencies in S1 beat 
and S2 beat, respectively. D1 and D2 are the LV-to-RV conduction delays in S1 beat and S2 
beat, respectively. The dashed line in panels B and C is the identity line whereby V1-V2=S1-
S2.   
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Figure 5. Effects of changes in the basic drive train cycle length on the ventricular action 
potential duration, effective refractory period, and conduction intervals during programmed 
stimulations. 
Programmed stimulations were applied at twice diastolic threshold current intensity with the 
S1-S1 cycle length of either 550 ms (open bars) or 300 ms (hatched bars). The left set of 
panels shows changes in left ventricular (LV) action potential duration (APD90, panel A), 
effective refractory period (ERP, panel D), and ERP-to-APD90 ratio (panel G) in the last S1 
beat in a drive train. The middle set of panels shows changes in LV activation latency (panel 
B), LV-to-RV delay (panel E), and total conduction time (CT) (panel H) determined in the 
last S1 beat in a drive train (first pair of bars) and in S2 beat evoked at the shortest ventricular 
capture interval (second pair of bars). The right set of panels shows S2 vs. S1 % increase in 
the activation latency (panel C), LV-to-RV delay (panel F), and total conduction time (panel 
I) determined with the two S1-S1 cycle lengths. *P<0.05. The same figure design is used in 
Figs. 6-8.  
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Figure 6. Effects of changes in the stimulating current intensity on the ventricular action 
potential duration, effective refractory period, and conduction intervals during programmed 
stimulations. 
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Figure 7. Effects of hypokalemia (HypoK) on the ventricular action potential duration, 
effective refractory period, and conduction intervals during programmed stimulations. 
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Figure 8. Effects of flecainide on the ventricular action potential duration, effective 
refractory period, and conduction intervals during programmed stimulations. 
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Table 1. An overview of experimental series and the programmed stimulation protocols used 
in the study. 
___________________________________________________________________________
____________________________________ 
Experimental series                      Sample size            Stimulation site           Basic drive cycle 
length           Stimulating current strength 
Testing effects produced                   n=9                    LV epicardium                 S1-S1=550 ms                       
2 times diastolic threshold 
by variations in parameters                                                                                   S1-S1=300 ms                       
2 times diastolic threshold 
of programmed stimulations                                                                                 S1-S1=550 ms                       
5 times diastolic threshold 
Testing effects produced by              n=11                  LV epicardium                 S1-S1=550 ms                       
2 times diastolic threshold 
hypokalemia (2.5 mM KCl)  
vs. normokalemia (4.7 mM KCl) 
Testing effects produced                   n=10                  LV epicardium                 S1-S1=550 ms                       
2 times diastolic threshold 
by flecainide (1.5 M) 
Testing effects of LV vs.                   n=7                    LV epicardium                 S1-S1=550 ms                       
2 times diastolic threshold 
RV stimulations                                                           RV epicardium                 S1-S1=550 ms                       
2 times diastolic threshold 
